MicroRNA-200 family members and ZEB2 are associated with brain metastasis in gastric adenocarcinoma
- 26 September 2014
- journal article
- research article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 45 (6), 2403-2410
- https://doi.org/10.3892/ijo.2014.2680
Abstract
Although the incidence of brain metastasis in gastric cancer is relatively low, its prevalence may increase with improved therapy and longer survival tumors. The molecular mechanisms underlying brain metastases are not well understood. To gain insight into the mechanism of brain metastasis, we studied differences in microRNA (miRNA) expression levels in 8 cases of matched primary gastric adenocarcinoma and brain metastatic adenocarcinoma using the Il lumina microRNA microarray chip. We identified 6 upregulated and 2 downregulated miRNAs in all 8 cases simultaneously. Interestingly, 2 out of 8 miRNAs (hsa-miR-141-3p and hsa-miR-200b-3p) belonged to the miR-200 family. Online microRNA database searching revealed that ZEB2 is the top-ranked target gene for hsa-miR141-3p and hsa-miR-200b-3p, prompting us to focus ZEB2 expression in brain metastatic adenocarcinoma. We confirmed that ZEB2 expression was markedly downregulated in some brain metastatic samples. In addition, decreased ZEB2 expression was noted by western blot analysis of 2 metastatic gastric adenocarcinoma cell types that were derived by in vivo selection following intracardiac injection of gastric cancer cell lines. In conclusion, we demonstrate that expression of miRNA-200 family members and ZEB2 are associated with brain metastases of gastric adenocarcinoma, not only in matched patient samples, but also in metastatic cell lines that were derived by in vivo selection.Keywords
This publication has 29 references indexed in Scilit:
- EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small-cell lung cancerExpert Review of Anticancer Therapy, 2012
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III StudyJournal of Clinical Oncology, 2011
- Leptomeningeal carcinomatosis associated with gastric cancerInternational Journal of Clinical Oncology, 2011
- Gastrointestinal cancer and brain metastasisCancer, 2011
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Gastric leptomeningeal carcinomatosis: Multi-center retrospective analysis of 54 casesWorld Journal of Gastroenterology, 2009
- Targeted Therapy for Brain Metastases: Improving the Therapeutic RatioClinical Cancer Research, 2007
- Cerebral metastasis from hepatoid adenocarcinoma of the stomachWorld Journal of Gastroenterology, 2007
- Does trastuzumab increase the risk of isolated central nervous system metastases in patients with breast cancer?Nature Clinical Practice Oncology, 2006
- Leptomeningeal carcinomatosis in gastric cancer.Journal of Neuro-Oncology, 2004